FDA Approves New Clinical Trial Design for the Study of CORTOSS in the Repair of Vertebral Compression Fractures of the Spine.
Business Wire › August 24, 2004
Linked as:
Extract
FDA Approves New Clinical Trial Design for the Study of CORTOSS in the Repair of Vertebral Compression Fractures of the Spine.
MALVERN, Pa. -- Orthovita Study Will Now Include a Direct Comparison of CORTOSS versus Polymethylmethacrylate (PMMA) Bone Cements in Treatment of Vertebral Fractures
Orthovita, Inc. (NASDAQ NM:VITA), a leading developer of orthopedic biomaterials, today reported that the FDA has approved the company's petition to amend the current pivotal clinical trial ...See the full content of this document
Sponsored links
